Study Design: Systematic review.
Introduction
Spinal epidural abscess (SEA) is a potentially life-threatening medical emergency that often warrants immediate medical (antibiotic) and/or surgical intervention. 1 SEAs develop through either direct spread from a contiguous site (vertebral osteomyelitis, overlying cellulitis, epidural injection) 2 or via hematogeneous seeding of the epidural space often seen in intravenous drug users, septic patients, or patients with generalized bacteremia. 3, 4 SEAs can progress rapidly and have the potential to cause irreversible neurological deficits when treatment is delayed. [5] [6] [7] [8] A recent study conducted by the Department of Veterans Affairs found that 55% (n ¼ 66) of all SEA cases were initially misdiagnosed. Time to correct diagnosis was 12 days in patients initially misdiagnosed, versus 4 days for patients properly diagnosed (P < .01). 9 Misdiagnosis in this study was most often the result of inadequate recognition of "red flag" signs (unexplained fever, progressive neurological deficits, active infection) and inadequate initial evaluation as performed by the treating physician (n ¼ 60; 90.1%).
Prior research on clinical manifestations and disease progression of SEAs found significant differences across spinal cord regions (cervical vs thoracic vs lumbar).
10-13 Khanna et al previously described more rapid and severe onset of neurological deficit in patients with cervical and thoracic SEAs relative to patients with lumbar SEA.
14 One possible explanation of this finding is that the smaller canal diameters in the thoracic spinal cord lead to more severe early compression of the spinal cord in the thoracic spine compared with the lumbar spine. In support of this theory, several studies have previously reported patients with SEAs of the thoracic spine presented more abruptly and with more severe neurological deficits when compared with similar patients with SEAs located in more caudal spinal cord levels. [15] [16] [17] Logical organization of information surrounding thoracic SEAs from a spine surgeon's perspective would ideally include the following components: (1) patient symptomology (typical signs and symptoms); (2) the clinical approach and diagnostic workup; (3) treatment failure and risk factors for failure of medical management (pharmacotherapy alone); (4) neurological recovery rates and effect of medical management versus surgical treatment, specifically, in relation to time to treatment; and (5) Indications for stabilization in patients presenting with thoracic SEAs. With this in mind, investigators are limited by the existing body of evidence as it relates to thoracic SEAs rather than SEAs of all spinal cord levels in general. Organization of information extracted depends heavily on the current research landscape.
Despite prior research indicating that thoracic SEAs expand and compress important spinal cord structures earlier than SEAs at other levels, there is a gap in the literature about optimal management of thoracic SEAs. For this reason, the present study focused on synthesizing the available evidence regarding clinical manifestations, natural history, and management of thoracic SEAs with the aim of reducing morbidity and mortality associated with misdiagnosis or delayed treatment.
9,14

Methods
Search Strategy
Investigators conducted a search review of 3 databasesMedline, Embase, and Cochrane Central-with the following search term strategy: ("Epidural Abscess" OR "SEA") AND ("Thoracic" OR "Thoracic Vertebrae"). Subsequent review of other literature sources (Google Scholar, PubMed) employed a similar search strategy (key terms: "Epidural Abscess" or "SEA" AND "Thoracic" OR "Thoracic Vertebrae"). In total, 693 articles were identified from the database and outside source search ( Figure 1 ). The search period ended June 28, 2017.
Inclusion and Exclusion Criteria
Articles were included if they reported results relating to epidural abscess of the thoracic spine. Retrospective cohort studies, prospective cohort studies, and clinical trials were the only study types included due to their superior quality of evidence when compared with case reports or expert advice. 18 Case reports were excluded from the current study.
Articles that did not stratify results by spinal cord region (cervical, thoracic, or lumbosacral) and articles that focused on spondylitis or spondylodiscitis or infection of the spinal cord in general without focus on epidural abscess of the thoracic spine were excluded.
Data Collection
Two trained reviewers (BH and ID) independently reviewed each study at each of the 4 stages described below. At each of the 4 stages, a third author (JT) acted as final arbiter when inclusion and exclusion disagreements arose. First, duplicates from the 693 articles were deleted and the remaining article titles were screened for inclusion. Second, among those studies that were included following the title review, full abstracts were read and inclusion and exclusion criteria were again reviewed. Third, after studies were included following abstract review, the full manuscript was reviewed and a final decision of inclusion or exclusion was made. Data extraction of the final sample of articles involved independent review of each article by 2 trained reviewers (BH and ID). Included articles were assessed for level of evidence based on the Oxford Center for Evidence Based Medicine (OCEBM) evaluation criteria.
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Results
Of the 693 articles obtained from the initial search, 480 remained after 213 duplicates were removed. An additional 452 articles were removed following the initial title review, and the resultant 27 remaining articles were screened based on abstract content alone. After this review, 2 additional articles were excluded following independent review of the full text content. In total, 25 articles (see the appendix) were included in the final analysis based on the aforementioned data collection methodology (Figure 1 ). Of the 25 articles, 24 articles were retrospective reviews and 1 was a prospective cohort. Articles were published between 1990 and 2017. Based on recurring themes found throughout included articles, our findings were separated into 5 categories: (1) clinical presentation, duration of symptoms, and risk factors; (2) radiological, microbiology, and laboratory findings; (3) pharmacological management; (4) surgical management; and (5) patient outcomes.
Of the 25 included articles, 22 (88%) provided case information on presenting symptoms, clinical progression, and risk factors associated with development of thoracic SEA prior to hospital admission (Table 1 ). Back pain (n ¼ 16; 64%), 3, 12, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] neurological deficits (n ¼ 17; 68%), 3, 12, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [32] [33] [34] [35] including paraparesis (n ¼ 12; 48%) 3, 20, 22, 24, 26, [28] [29] [30] [33] [34] [35] [36] and paraplegia (n ¼ 5; 20%), 22, 24, 28, 34, 35 fever (n ¼ 6; 24%), 3, 21, 23, 24, 26, 29 and loss of bowel or bladder control (n ¼ 4; 16%) 22, 25, 26, 34 were among the most commonly reported symptoms present at time of admission. Clinical progression and time to admission following onset of symptoms was variable, but largely underreported by investigators. Of the 3 studies that did report clinical progression from onset of symptoms to follow-up after surgery, 2 studies documented the presence of pain occurring first followed by progression to concomitant pain with neurological deficits (8%). 25, 35 Hadjipavlou et al noted that back pain generally preceded the onset of neurological deficits. 35 Kuker et al reported a similar pattern of preceding back pain prior to the onset of neurological deficits in patients diagnosed with thoracic SAE. However, in their study the lag between pain and neurological symptoms was highly variable (median: 2.7 months). 25 According to Boström et al, patients waited between 12 hours to several months from time of symptom onset (back pain, weakness, neurological dysfunction) to present for medical treatment of thoracic epidural abscess. 32 Risk factors for developing thoracic SEA can be divided into either modifiable or nonmodifiable risk factors. Among the modifiable risk factors, alcoholism and intravenous drug use were most strongly associated with thoracic SEAs. 3, 12, 21, 32 Bacteremia caused by nonsterile injection needles was the most commonly identified preventable risk factor (n ¼ 3; 12%). However, thoracic SEA has been observed after lumbar epidural steroid injections as well. 
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Global Spine Journal 8(4S) 12, 26, 37, 38 and AIDS (n ¼ 2; 8%). 27, 35 History of diabetes mellitus was also reported as a risk factor for the development of thoracic SEA (n ¼ 7; 28%). 27, 28, 33, 35, 36, 38 Radiographic, Microbiology, and Laboratory Findings Diagnosis and monitoring (imaging and laboratory testing) for treatment response was described in 23 of the included articles (92%; 29 imaging were noted in 6, 3, and 1 of the articles that met inclusion criteria, respectively. Curry et al demonstrated the utility of MRI with gadolinium contrast (71%) and CT myelography (29%) in the diagnosis of thoracic SEA among cases subsequently diagnosed with thoracic SEA at time of surgery. 21 Kuker et al further supported the utility of MRI with gadolinium in the conformation of thoracic SEA and went on to suggest that signal changes in T2-weighted images may be among the first signs of disc space infection. 25 Other diagnostic modalities utilized in the diagnostic process included myelography (n ¼ 2; 8%) 24, 26 and plain film radiographs (n ¼ 1; 4%), although the latter was less specific for epidural abscess within the thoracic spine and more specific to purulent disc space infection. 28 Seven studies reported the use of C-reactive protein (CRP) and/or erythrocyte sedimentation rate (ESR) in SEA disease identification and subsequent treatment response monitoring. Boström et al defined an elevated CRP as greater than 5 mg/dL with 78% of cases included in this study having a pretreatment CRP value between 23 and 230 mg/dL. Authors did not specifically define ESR thresholds before and after treatment; however, in the case of Kuker et al and Boström et al, the authors noted that elevated readings were defined as values above normal laboratory cutoff points (0-22 mm/hour for men and 0-29 mm/hour for women). 25, 32 Similarly, Kuker et al found that pretreatment CRP values were elevated in 100% of reported cases. 25 ESR was found to be consistently elevated in patients presenting with thoracic epidural abscess as seen in Kuker et 35 The most frequently reported causative bacteria was Staphylococcus aureus (n ¼ 18; 72%; Table 2) . 3, 21, 22, [25] [26] [27] [28] [29] [30] [31] [33] [34] [35] [36] [37] [38] [39] [40] Abdelrahman et al found no age predilection for infection with S aureus (P ¼ .074). 36 Methicillin-sensitive S aureus (MSSA) was the causative bacteria in nearly 30% of patients reported by Curry et al and 40% of patients reported by Patel et al. Curry et el also found methicillin-resistant S aureus (MRSA; 31%) to be slightly more common than MSSA (30%) in patients admitted for thoracic SEA; thus, abscess culture and sensitivity profiles are necessary for effective treatment, as the pharmacological therapy for MSSA is ineffective against MRSA. 21 Less commonly reported bacterial strains cultured from thoracic epidural abscess aspirates included S epidermidis, 41 other coagulase negative Staphylococcus species, 32 gram negative rods, Streptococcus agalactiae, 25 and Streptococcus pyogenes (Table 2) . 28 While Mycobacterium tuberculosis (TB) has a very different bacterial lifecycle and spread relative to the other bacterial strains previously discussed, 3 included articles focused on this bacterial species as a cause of thoracic SEA. 27, 33, 42 Research in these studies found that these bacteria spread hematogeneously to the thoracic epidural space, as opposed to the majority of cases caused by S aureus that colonized the epidural space via direct extension. Additionally, these studies demonstrated that special aerobic culture on TB-specific media needed to be undertaken for proper diagnosis of this offending organism, as typical gram stain and culture would fail to diagnose the acid-fast bacterial species.
Pharmacological Management
Pharmacological management of thoracic SEAs was described in 13 of the included articles (52%). All 10 studies that reported pre-and postoperative antibiotic choice indicated that therapy was guided by sensitivity profiles obtained through bacterial culture (n ¼ 10; 100%; Table 3) . 20, 26, 27, 30, 32, 33, 35, [40] [41] [42] Pharmacotherapy failure was described in 2 of the articles. Curry et al focused on the effect of failed medical management (pharmacotherapy) with subsequent delayed surgical treatment of epidural abscess. 22 Authors found that patients who received antibiotics and failed to clear their infection had significantly worse outcomes (ie, progression of neurological deterioration or reduced improvement in neurological symptoms following operation) compared with patients who received antibiotics and immediate surgical treatment (P < .005). 22 Patel et al identified 3 predictors of medical management failure: (1) CRP >115 (odds ratio [OR] 4.7, P ¼ .045), (2) WBC >12.5 (OR 3.3, P ¼ .045), and (3) positive blood cultures (OR 3.5, P ¼ .035). Patients that did not have any of these risk factors at time of therapy were predicted to have an 8.3% risk of failing pharmacotherapy, whereas patients with 1 of 3, 2 of 3, or 3 of 3 of these risk factors were predicted to have a 35.4%, 40.2%, and 76.9% pharmacotherapy failure risk, respectively. 28 
Surgical Management and Patient Outcomes
Surgical treatment of thoracic SEA was discussed in 16 of the included articles (Table 4) . 3, 20, [24] [25] [26] [27] 29, 30, [33] [34] [35] 37, 38, 40, 42 Patient outcomes following surgery were discussed in 15 of these articles. 3, 20, [24] [25] [26] [27] 29, 30, [33] [34] [35] 37, 38, 40 Results of the following surgical techniques were reported in the included studies: laminectomy (n ¼ 10; 63%), hemilaminectomy (n ¼ 2; 13%), decompression and debridement/evacuation (n ¼ 7; 44%), corpectomy with instrumentation (n ¼ 2; 13%), and continuous irrigation through a laminotomy (n ¼ 1; 6%). Surgical technique was based on the location of the SEA within the thoracic spine in 5 studies (31%), patient clinical status in 1 study (6%), and preoperative laboratory and imaging findings in 3 studies (19%). Seven articles discussed decision making criteria (Table 5) . 3, 20, 27, 32, 35, 38, 42 In an earlier study by Wang et al, all patients were treated surgically with laminectomy and antibiotics pre-and postoperatively for variable durations. Of the 9 patients being treated for thoracic SEA, 7 had paraparesis/ paraplegia at time of surgery and 6 did not recover following laminectomy, with 5 patient deaths during the postoperative follow-up period. Patients with severe preoperative motor dysfunction also had the most postoperative dysfunction with no (continued) association between length of antibiotic treatment postoperative and patient recovery. 30 Later studies by Wang et al found similar poor rates of recovery (20%) in patients with severe preoperative neurological deficit presenting with SEA of the cervical, thoracic, and/or lumbar spine. These reports showed isolated thoracic SEA had no recovery versus 50% recovery rates in patients with isolated lumbar SEA. 40 Thalia et al further demonstrated that a patient's preoperative American Spinal Injury Association (ASIA) motor score was a better predictor of postoperative ASIA motor scores in comparison to antibiotic duration or preoperative risk factors. 29 Of the 6 thoracic patients included in the overall study, 2 had improvement in ASIA motor score (1 by 1 point and 1 by 3 points) and 4 had no change at 3 months postoperation. At 12 months, 4 (67%) had improved ASIA motor scores.
Patel et al compared patients treated with antibiotics alone (group 1), immediate surgery (laminectomy, anterior discectomy and fusion, corpectomy, or posterior spinal instrumentation with fusion) and antibiotics based on severity and location of SEA (group 2), or antibiotics followed by delayed surgery with antibiotics due to treatment failure (group 3). These studies found that 41% of patients treated with antibiotics alone failed to resolve the infection and eventually required surgical intervention. Irrespective of surgical approach, all patients treated surgically immediately had improvement in ASIA motor score (mean improvement of 3.37 points). Patients who failed medical management and required delayed surgical intervention had significantly worse outcomes (lower motor scores or increased pain postoperatively) compared with patients treated with immediate antibiotics and surgery. Patel et al also found that significant predictors of medical management failure were a CRP level >115, a WBC count >12.5, and blood cultures positive for bacteria (bacteremia). 3 Similarly, de la Fuente Aguado et al reported favorable outcomes in the 2 (66%) thoracic SEA cases treated with immediate laminectomy compared with the 1 case (33%) that was treated with conservative management and had a fatal outcome. 24 Connor et al reported that surgical interventions were initiated immediately whenever thoracic SEA cases presented with acute motor strength loss. 20 Patients treated with posterior laminectomy had improved, stable, or worsening neurological outcomes at follow-up in 79%, 8%, and 13% of cases, respectively. Older age (P ¼ .04) and greater premorbid weakness (P ¼ .012) were associated with worse postoperative outcome. Furey et al analyzed data on 12 cases of thoracic SEAs treated with either surgical decompression and evacuation for posterior SEA or anterior decompression with structural allograft and staged posterior instrumented fusion for anterior SEA. They found no difference in outcome or survival between location and surgical approach used. 38 Risk factors associated with mortality in this study were age >70 years (P ¼ .01), neurological deficits present >5 days prior to surgery (P ¼ .04), a preoperative ASIA D motor score (P ¼ .01), diabetes mellitus (DM; P ¼ .01), MRSA sepsis (P ¼ .03), and end-stage renal disease (ESRD; P ¼ .02). 38 Of note, the authors were surprised by the aforementioned increase in mortality associated with lower presurgical ASIA D score. One potential explanation for this could be delayed surgical intervention in patients with less severe symptoms and subsequently worse outcomes associated with the delay. Liem et al also found that patients with more severe preoperative symptoms did better if rapid decompression occurred within 24 hours of symptoms compared with patients who had delays in surgical decompression greater than 24 hours from time of onset. Of the 11 patients treated with laminectomy and drainage (52%), 2 of them deteriorated and required anterior corpectomy. The remaining 10 patients were treated with transthoracic corpectomy and fixation (n ¼ 5; 24%), costotransversectomy (n ¼ 1; 5%), or percutaneous aspiration (n ¼ 1; 5%). Patients with anterior pathology who initially underwent laminectomy did poorly compared with patients where the anterior lesion was approached directly from an anterior approach. Development of sepsis (n ¼ 3; 14%) during initial hospitalization was fatal in all cases and patients If primary epidural abscess was present emergency laminectomy was performed. If there was instability present in these cases, posterior instrumentation and fusion was recommended. If epidural abscess was present secondary to spondylodiscitis and the abscess was anteriorly located then posterior instrumentation, deformity correction, and fusion were recommended in combination with anterior decompression. In the case of posterior abscesses secondary to spondylodiscitis, again, emergent laminectomy, posterior stabilization and fusion, and corrective deformity was recommended in combination with anterior decompression and fusion. Nakase et al (2006) Instrumentation and stabilization when structural instability was present. Patel et al (2014) Severity and location of the pathology dictated treatment approach. Yang et al (2016) Surgery was performed when erythrocyte sedimentation rate decreased and C-reactive protein was within normal range.
who presented with worse neurological symptoms preoperative had worse outcomes. 26 No included articles compared surgical treatment approach efficacy or specifically compared outcomes associated with varied surgical approaches. As noted above, Liem et al did find more favorable outcomes with a direct approach compared with a posterior laminectomy in patients with anterior thoracic SEAs; however, no major comparisons were made between other surgical techniques used for posteriorly located abscesses, and post hoc analysis for anterior approach was limited.
Discussion
Thoracic SEA is a serious and potentially life-threatening medical emergency if left untreated. This systematic review compiled previously published studies to bridge gaps in relevant clinical knowledge. To this aim, the authors included 25 articles and extracted information on outcomes and treatment of thoracic SEA. Information from included articles was grouped into 1 of 5 categories: (1) clinical presentation, duration of symptoms, and risk factors; (2) radiological, microbiology, and laboratory findings; (3) pharmacological management; (4) surgical management; and (5) patient outcomes.
Surgical Management and Patient Outcomes
To our knowledge, no formalized guidelines exist for the treatment of thoracic SEAs, specifically. Prior systematic reviews on SEAs at all levels have compared treatment modalities by spatial orientation around the spinal cord (anterior, posterior, posteriolateral). However, these prior approaches have not focused to any large extent on anatomical-specific outcomes that are relevant to the thoracic spinal cord level specifically (faster rate of cord compression, higher incidence of paraparesis/paraplegia compared with other levels, worse recovery rates compared with other levels). Rather, treatment approach in the majority of included cases involved 3 components: (1) broad-spectrum empiric antibiotics after abscess biopsy, (2) targeted antibiotics based on cultured sensitivity profiles for the bacteria, and (3) surgical decompression þ/-instrumentation. Results from included studies further demonstrate that patient outcomes between studies, even when presenting with similar preoperative neurological deficits, are highly variable. Heterogeneity in patient outcomes highlights the need to better understand which approaches to surgical management of thoracic SEAs produce the best patient outcomes.
None of the included articles directly compared different surgical approaches for treatment of thoracic SEAs. While Liem et al found improved outcomes when anterior located thoracic SEAs were treated using an anterior approach versus a posterior laminectomy, no detailed comparisons were made between outcomes associated with different surgical approaches. Surgical complications were not compared between the types of surgery. Results obtained from this systematic review underscore a need for randomized clinical studies aimed at comparing efficacy of different surgical approaches based on location of the abscess. It is important to note that the included studies did not characterize the preoperative spinal stability or alignment (ie, in cases of osteomyelitis) well enough to make meaningful conclusions about types of surgical intervention. However, from the literature and in the authors' experience, it is clear that reconstruction with stabilization should be added in cases of spine instability and kyphosis.
Results outlined in this systematic review can aid spine surgeons in developing methodologies capable of addressing our current gaps in knowledge. First, the majority of studies included reported improved outcomes with immediate surgical intervention and antibiotics, 3, 20, 24, 26, 38 and as previously discussed, up to 55% of patients presenting with SEAs are initially misdiagnosed with significant delays in treatment. 9 Furthermore, as noted above, results presented by Hadiipavlou et al and Abdelrahman et al on neurological deficits and neurological recovery following spinal decompression for SEA, respectively, demonstrated a significantly higher rate of paraplegia/ paraparesis prior to surgery and a significantly lower recovery rate following surgical decompression in patients with SEAs at the thoracic level compared with other levels. 35, 36 In light of these findings, early diagnosis and aggressive surgical decompression when neurological deficits are present is a reasonable approach and can help reduce the greater likelihood of persistent morbidity in this patient population. With that said, a large degree of bias exists within the current literature regarding patients included in published studies (more often sicker patients with greater neurological deficit at time of admission). This selection bias in patient population complicates external validity to a less or nonneurologically impaired patient population. Clinical judgement and vigilance obtained through recognition of characteristic signs and symptoms in addition to laboratory and radiological findings can aid spine surgeons in increasing speed of thoracic SEA diagnosis and management. Second, risk factors associated with increased mortality (ASIA D score, DM, MRSA sepsis, ESRD, age >70, and neurological deficits present >5 days prior to surgery) can aid in the design of surveillance programs for spine surgeons. For example, patients with multiple risk factors for the development of a thoracic SEA following spine surgery could be educated on warning signs associated with development of thoracic SEAs (back pain, fever, paraparesis, and other signs of neurological deficit) with the goal of quicker diagnosis and surgical intervention. Third, risk factors for medical management failure could be adapted into an algorithm to predict medical management failure based on risk factors and presenting symptoms. This algorithm could stratify immediate surgical management with medical management versus permissive medical management alone in patients who are predicted to have a low calculated predictive risk of medical management failure based on a predetermined threshold. This would allow spine surgeons to optimize treatment outcomes, while also addressing the potential for unnecessary costs associated with
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Global Spine Journal 8(4S) surgical intervention among patients with low risk of medical management alone failure. Future studies with a larger sample size, greater statistical power, and randomized controls could yield valuable data to power statistical models capable of predicting which patients are at greatest risk for developing thoracic SEAs, more likely to fail medical management, and which surgical approaches are most efficacious for thoracic SEAs accounting for approach (anterior, posterior, anterolateral). While the execution of a randomized controlled trial in this patient population is difficult, if not impossible, prospective comparative trials are certainly within the realm of possibility at tertiary centers.
Clinical Presentation and Duration of Symptoms
Recognizing signs and symptoms associated with the presence of thoracic SEAs is essential for the initial diagnosis and subsequent timely management. Despite characteristic patient presentation (back pain, fever, and neurological deficit), 26 ,32 the diagnosis of thoracic SEA is often missed and patients are not adequately diagnosed during the initial encounter. 9 One possible reason for the diagnostic error is primary care and emergency medicine physicians reluctance to order expensive MRI capable of visualizing abscess foci. In this case, physician education would be essential for reducing diagnostic errors in patients presenting with thoracic SEAs. Importantly, the duration of symptoms prior to time of admission can be quite variable and a high level of suspicion is warranted, especially among patients with relevant risk factors (intravenous drug use, AIDS and immunocompromised, DM, and chronic renal failure). More controlled studies with larger patient cohorts would afford researchers an adequate sample size (beta) for logistical regression models capable of predicting adverse events of interest (medical management failure, development of thoracic SEA, patient mortality, etc). Additionally, a larger controlled patient population would allow researchers to better characterize initial presenting symptoms (signs, symptoms, duration) with a standardized data-collection protocol, rather than the amalgam of varied research tools presented in this systematic review. Finally, more specific recommendations on how long to continue antibiotics after ESR/CRP laboratory values normalize would provide clinicians more definitive guidance on needed length of pharmacotherapy in patients presenting with thoracic SEA.
Radiological, Laboratory, and Microbiology Findings
Aside from the initial patient history and physical, radiological and laboratory findings are often the only other data points available in guiding clinical decision making. CRP and ESR are 2 commonly monitored inflammatory markers used before and after surgical/antibiotics. CRP was nearly always elevated in patients presenting with thoracic SEAs with levels decreasing to baseline indicative of a successful treatment response. Based on results of this review, all patients with suspected thoracic SEA should undergo bloodwork to measure CRP, ESR, and WBC. MRI with gadolinium contrast and/or CT imaging with or without myelography were found to have high sensitivity and specificity capable of determining treatment response following antibiotics and surgical decompression. As such, MRI and CT are reasonable initial diagnostic modalities and can aid spine surgeons in localizing the thoracic abscess within the epidural space. As mentioned above, future studies aimed at comparing the efficacy between different surgical techniques based on thoracic SEA location (anterior, posterior, etc) will require a detailed knowledge of abscess location prior to preparation for surgical approach. Furthermore, serial monitoring of ESR, CRP, WBC, and/or MRI/CT has the potential to guide duration of antibiotic treatment. This duration is important given the rise in antibiotic resistance, antibiotic stewardship programs, and the cost associated with longer duration of unnecessary antibiotics following SEA resolution. [39] [40] [41] Most often infections of the thoracic epidural space were caused by S aureus, although M tuberculosis, other coagulase negative Staphylococcus, gram negative rods, and mixed microbial infections are reported to a lesser extent. With this in mind, empirical therapy following thoracic SEA biopsy should include broad spectrum antibiotics normally used to cover the most commonly implicated microorganisms (MSSA, MRSA, other coagulase negative Staphylococcus species).
Pharmacological Management
Pharmacological therapy was based on cultures obtained from thoracic SEA biopsy. Biopsy should be obtained prior to initiation of pharmacotherapy rather than initiating broad spectrum antibiotics before sample collection, as the latter can compromise ability to culture aspirates and limits ability to obtain bacterial sensitivity profiles for more tailored medical management. Length of antibiotics for treatment of abscess varied by study, but a number of reports monitored serial ESR and CRP laboratory values to monitor infection response, with slower responses requiring longer courses of antibiotic therapy. 24, 27 As mentioned above, with growing concern over antimicrobial resistance exceeding our ability to produce novel antibiotics to counter such resistance, it is important to protect our antimicrobial arsenal from unnecessary resistance caused by inappropriate antibiotic use.
Use of pharmacological therapy (medical management) was ubiquitous across studies; however, the literature is largely lacking in terms of comparison between medical management alone for thoracic SEA, specifically, versus immediate surgical intervention with focused antibiotic treatment. Importantly, Patel et al reported rates as high as 41% for failure of antibiotic therapy alone without combined surgery. 3 Based on cases presented by Patel et al, patients who failed antibiotic therapy and needed delayed surgery for treatment of abscess had a statistically significant worse outcomes compared with patients treated immediately at admission with decompression (ie, irreversible neurological deficits). Future studies with a larger patient population with thoracic SEAs is necessary to better characterize factors associated with failure of medical management and subsequent risk of worsening neurological sequelae.
Limitations and Future Study
To address this clinical entity, investigators initially aimed to further characterize thoracic SEAs based on presentation and clinical workup. In addition, they aimed to discuss surgical considerations, specifically, the importance of surgical and/or medical management timing in relation to patient risk factors and subsequent patient outcomes, general rates of neurological recovery following immediate versus delayed surgical management, and specific surgical approaches. However, several limitations became evident during the systematic review process. First, despite initial objectives, investigators soon found that much of the past and current literature does not stratify patient findings based on spinal cord level. As such, synthesis of extracted data was limited. Second, the majority of articles yielded from the initial database query process were simple case reports and did not meet the eligibility criteria for inclusion in this study. Our final smaller list of eligible articles provided some invaluable information with regard to patient risk factors, presentation, microorganisms involved, and response to varied treatment approaches. Limited overlap between content analyzed in each included article was less than ideal for comparison between studies. However, despite limited overlap in protocol and study focus, meaningful results capable of informing clinical decision making were still able to be extracted from included studies and discussed in the current review. Third, because thoracic SEAs are a fairly rare clinical entity seen at any one regional research center, enrolling enough patients for randomized clinical trials or larger cohort studies would be difficult and likely require a multicenter collaboration and multiple years of enrollment, data collection, and analysis. Fourth, the majority of included articles did not carry out any sort of exhaustive statistical analysis to identify significance factors, odds ratios, group mean differences, and other metrics useful in patient safety and quality improvement. Last, external validity and generalizability is stymied, in part, by a selection bias in favor of including patients with greater neurological deficit rather than patients without significant impairment at time of admission. Future studies involving a greater degree of variance in patient population (age, presenting neurological status at time of admission, comorbid disease history) as well as a greater sample size can further aid spine surgeons in attaining improved outcomes in patients presenting with thoracic SEA.
Conclusion
The present systematic review addresses a significant gap in the field of spine research. For the first time researchers have focused specifically on SEAs of the thoracic level, as opposed to previously published general analysis of SEAs as a whole. Given the fact that thoracic SEAs are quicker to progress and compress vital cord structures, the combination of results presented and relevant clinical experience can be used by spine surgeons and other providers to reduce morbidity and mortality in their patient populations. Based on the results, investigators recommend early MRI imaging of the spine, laboratory workup (ESR/CRP, complete blood count), abscess culture followed by empiric antibiotics, and immediate surgical decompression when neurological deficits are present.
